PTC THERAPEUTICS, INC. ($PTCT)
Boulding Mark Elliott โ EXEC. VP AND CLO
Shares
2,813
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 19, 2026
EPS:Est: -0.21
Revenue:Est: $289.25M
Feb 26, 2026
EPS:Est: -0.21
Transaction Details
| Insider | Boulding Mark Elliott |
|---|---|
| Title | EXEC. VP AND CLO |
| Transaction Date | Feb 17, 2026 |
| Expiration Date | Feb 14, 2034 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Shares Purchased | 2,813 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 22,501 |
| Derivative | Derivative |
| Accession Number | 0001578852-26-000008 |
| Document | View SEC Filing |